Tuesday, 02 January 2024 12:17 GMT

Managing Service Providers Including CRO And Cmos Oversight To Comply With ICH GCP R3 Scheduled For October 1415, 2027


(MENAFN- GlobeNewsWire - Nasdaq) Rising regulatory scrutiny is driving demand for robust pharma vendor selection, oversight, KPI tracking and CRO performance management, creating opportunities for training and consulting.

Dublin, Sept. 16, 2026 (GLOBE NEWSWIRE) -- "Managing Service Providers including CRO (Contract Research Organisation) and CMOs oversight to comply with ICH GCP (Good Clinical Practice) R3 Training Course (Oct 14th - Oct 15th, 2026)" has been added to ResearchAndMarkets.com's offering.

The Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3 training course will take place online on October 14–15, 2027. Delivered by IPI Academy, the two-day programme addresses sponsor oversight of outsourced activities, risk-based management and demonstrable control of service providers following the implementation of ICH GCP E6(R3).
The course focuses on preparing requests for proposal (RFPs), evaluating and selecting CROs, establishing vendor oversight procedures for R&D projects, managing CRO and vendor relationships, and addressing performance issues. It also examines the shared responsibilities of sponsors and service providers and is designed to support both organisations outsourcing activities and CROs, vendors and consultants working with sponsor organisations.
Why You Should Attend

  • Understand regulatory expectations: Examine CRO/vendor oversight and the expectations of regulatory inspectors.
  • Strengthen vendor selection: Review CRO selection, bidding processes and the development of effective outsourcing relationships.
  • Manage project set-up: Explore approaches to managing vendor/CRO project initiation.
  • Apply ongoing oversight: Examine ongoing management and oversight throughout outsourced projects.
  • Review project performance: Learn about reviewing CROs during and at the end of a project.

The training is relevant to personnel involved in CRO/vendor management and oversight across pharmaceutical, biotechnology, animal health and medical device organisations, including clinical research, regulatory affairs, pharmacovigilance, manufacturing, clinical outsourcing, contracts, quality, clinical operations, vendor management and global QA/compliance. It also addresses outsourcing, purchasing, finance and contract management staff participating in the RFP process. The programme provides 12 CPD hours.
Featured Course Expert
Dr Laura Brown, Independent Pharmaceutical QA and Training Consultant; Senior Lecturer, MSc in Clinical Research, School of Pharmacy, University of Cardiff: More than 20 years' pharmaceutical industry experience, including senior roles with GSK, Hoechst Marion Roussel and Phoenix International, with expertise in CRO selection, management, oversight audit and quality systems.
With the online training scheduled for October 14–15, 2027, professionals responsible for outsourced activities and service-provider oversight can review the programme and register their interest through Research and Markets


For more information about this training visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN16092026004107003653ID1111672909



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story